Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
16 03 2021
Historique:
entrez: 2 3 2021
pubmed: 3 3 2021
medline: 15 9 2021
Statut: ppublish

Résumé

HTLV-1-associated myelopathy (HAM/TSP) is a chronic and progressive inflammatory disease of the central nervous system. The aim of our study was to identify genetic determinants related to the onset of HAM/TSP in the Japanese population. We conducted a genome-wide association study comprising 753 HAM/TSP patients and 899 asymptomatic HTLV-1 carriers. We also performed comprehensive genotyping of

Identifiants

pubmed: 33649182
pii: 2004199118
doi: 10.1073/pnas.2004199118
pmc: PMC7980450
pii:
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Competing interest statement: S.K. and F.M. are board members of GenoConcierge Kyoto Inc. S.K., M. Shimizu, and F.M. have patents pending for HLA typing software, primer sets for PCR amplification of HLA genes and its experimental protocol, and a risk marker of DRB1-GB-7 for HAM/TSP development.

Références

Nat Genet. 2012 Jan 29;44(3):291-6
pubmed: 22286218
Lancet. 1986 May 3;1(8488):1031-2
pubmed: 2871307
J Acquir Immune Defic Syndr (1988). 1990;3(11):1096-101
pubmed: 2213510
BMC Genomics. 2013 May 28;14:355
pubmed: 23714642
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Lancet. 1985 Aug 24;2(8452):407-10
pubmed: 2863442
Ann Neurol. 1988;23 Suppl:S143-50
pubmed: 2894806
Front Microbiol. 2012 Nov 09;3:389
pubmed: 23162542
Orphanet J Rare Dis. 2016 May 25;11(1):69
pubmed: 27225443
AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1047-61
pubmed: 11485622
J Virol. 2006 Nov;80(21):10683-91
pubmed: 16943297
Am J Hum Genet. 2008 Oct;83(4):445-56
pubmed: 18817904
Dev Comp Immunol. 2005;29(11):917-38
pubmed: 15936075
J Neurovirol. 1998 Dec;4(6):586-93
pubmed: 10065900
J Natl Cancer Inst. 1998 Apr 15;90(8):617-22
pubmed: 9554445
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Feb 1;17(2):167-70
pubmed: 9473019
Nucleic Acids Res. 2015 Jan;43(Database issue):D423-31
pubmed: 25414341
J Hum Genet. 2016 Jun;61(6):547-53
pubmed: 26911352
Blood. 1977 Sep;50(3):481-92
pubmed: 301762
PLoS One. 2010 Apr 27;5(4):e10207
pubmed: 20436909
N Engl J Med. 2018 Feb 8;378(6):529-538
pubmed: 29414279
Iran J Immunol. 2007 Jun;4(2):94-100
pubmed: 17652849
Nucleic Acids Res. 2015 Jan;43(Database issue):D784-8
pubmed: 25414323
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Hum Mutat. 2017 Jul;38(7):788-797
pubmed: 28419628
J Med Virol. 2012 Feb;84(2):327-35
pubmed: 22170555
Leuk Res. 2017 Oct;61:18-24
pubmed: 28866351
Int J Cancer. 1999 Jun 11;81(6):859-64
pubmed: 10362130
Nature. 1981 Dec 24;294(5843):770-1
pubmed: 6275274
J Neurol. 2013 Oct;260(10):2551-5
pubmed: 23835632
J Infect Dis. 2000 Nov;182(5):1343-9
pubmed: 11010842
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53
pubmed: 10097126
Med Microbiol Immunol. 2009 Feb;198(1):1-3
pubmed: 18521626
Am J Hum Genet. 2003 Nov;73(5):1162-9
pubmed: 14574645

Auteurs

Marina Penova (M)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan.

Shuji Kawaguchi (S)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan.

Jun-Ichirou Yasunaga (JI)

Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Sakyo-ku, 606-8507 Kyoto, Japan.

Takahisa Kawaguchi (T)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan.

Tomoo Sato (T)

Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, 216-8511 Kanagawa, Japan.

Meiko Takahashi (M)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan.

Masakazu Shimizu (M)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan.

Mineki Saito (M)

Department of Microbiology, Kawasaki Medical School, Kurashiki, 701-0192 Okayama, Japan.

Kunihiro Tsukasaki (K)

Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, 350-1298 Saitama, Japan.

Masanori Nakagawa (M)

Department of Neurology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kamigyo-ku, 602-8566 Kyoto, Japan.

Norihiro Takenouchi (N)

Department of Microbiology, Kansai Medical University, Hirakata, 573-1010 Osaka, Japan.

Hideo Hara (H)

Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, 849-8501 Saga, Japan.

Eiji Matsuura (E)

Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8544 Kagoshima, Japan.

Satoshi Nozuma (S)

Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8544 Kagoshima, Japan.

Hiroshi Takashima (H)

Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8544 Kagoshima, Japan.

Shuji Izumo (S)

Department of Molecular Pathology, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, 890-8544 Kagoshima, Japan.

Toshiki Watanabe (T)

The Institute of Medical Science and Future Center Initiative, The University of Tokyo, Kashiwa, 277-0871 Chiba, Japan.

Kaoru Uchimaru (K)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Minato-ku, 108-8639 Tokyo, Japan.

Masako Iwanaga (M)

Department of Frontier Life Sciences, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8588 Nagasaki, Japan.

Atae Utsunomiya (A)

Department of Hematology, Imamura General Hospital, Kagoshima, 890-0064 Kagoshima, Japan.

Yasuharu Tabara (Y)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan.

Richard Paul (R)

Institut Pasteur-Kyoto University International Mixed Research Unit for Vaccinomics, Institut Pasteur, 75015 Paris, France.

Yoshihisa Yamano (Y)

Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, 216-8511 Kanagawa, Japan.

Masao Matsuoka (M)

Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Sakyo-ku, 606-8507 Kyoto, Japan.
Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Chuo-ku, 860-8556 Kumamoto, Japan.

Fumihiko Matsuda (F)

Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Sakyo-ku, 606-8507 Kyoto, Japan; fumi@genome.med.kyoto-u.ac.jp.
Institut Pasteur-Kyoto University International Mixed Research Unit for Vaccinomics, Institut Pasteur, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH